Reverb Therapeutics Raises USD $12 Million Seed Round Financing to Harness Cytokine Signaling With its Amplify•R™ Platform
February 19, 2025
Opna Bio Receives Orphan Drug Designation for OPN-6602, an Oral EP300/CBP Bromodomain Inhibitor, for Multiple Myeloma
February 12, 2025
Statement from The Multiple Myeloma Research Foundation (MMRF) on Distinguished Business Leader Richard Parsons
December 27, 2024
Sarclisa (isatuximab): A New Option for Patients With Newly Diagnosed Myeloma Not Eligible for Transplant
December 23, 2024
MMRF Patient Navigator Q&A: Nursing Insights From the NCCN and JADPRO Annual Meetings
December 18, 2024
Indapta Therapeutics Secures $22.5 Million to Advance Clinical Trials of Innovative Cancer and Autoimmune Treatments
December 18, 2024
Multiple Myeloma Research Foundation Partners with Family Reach to Deliver Critical Financial Support to Multiple Myeloma Patients and their Families
December 11, 2024
Multiple Myeloma Research Foundation (MMRF) Programs Power New Insights into High-Risk Multiple Myeloma at the 66th American Society of Hematology Annual Meeting
December 6, 2024
The Multiple Myeloma Research Foundation (MMRF) Announces the First Patient Enrolled in its Horizon Clinical Trials Program to Accelerate the Identification of Optimal Treatment Strategies for Multiple Myeloma
December 4, 2024
Meet Elizabeth Bohannon, the Spirit of Hope Honoree for the MMRF Walk/Run: San Francisco
December 1, 2024
Meet Team Dial, Participating in Memory of Pastor Steven Dial Sr., MMRF 2024 Walk/Run: Atlanta Spirit of Hope Honoree
October 17, 2024
Multiple Myeloma Research Foundation (MMRF) Presents New Data from Multiple Myeloma Research Programs at the 21st International Myeloma Society Annual Meeting
September 25, 2024
